Chronic Ischemic cardiopathy

Chronic Coronary Syndromes

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases...

Dr. Omar Tupayachi - 28 November, 2025

Antiplatelet

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially...

Dr. Omar Tupayachi - 13 November, 2025

Chronic Ischemic cardiopathy

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been...

Dr. Omar Tupayachi - 13 November, 2025

Antiplatelet

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention...

Dr. Omar Tupayachi - 12 November, 2025

Calcified Lesions

CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice,...

Dr. Omar Tupayachi - 10 November, 2025

Chronic Ischemic cardiopathy

TCT 2025 | TUXEDO-2: Ultra-Thin Struts Versus Xience in Diabetic Patients with Multivessel Disease

It is well known that diabetic patients undergoing PCI often present with more extensive coronary artery disease,...

Dr. Andrés Rodríguez - 29 October, 2025

Chronic Coronary Syndromes

Functional Assessment of Coronary Stenoses: Hyperemic, Non-Hyperemic, and Angiographic Alternative Indices

Traditionally, the functional evaluation of coronary stenoses is performed through measurement of the fractional flow reserve (FFR)...

Dr. Juan Manuel Pérez - 15 October, 2025

Chronic Coronary Syndromes

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the...

Dr. Omar Tupayachi - 6 October, 2025

Chronic Ischemic cardiopathy

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

CALIPSO: Calcified Lesions and Use of OCT

TCT 2025 | TUXEDO-2: Ultra-Thin Struts Versus Xience in Diabetic Patients with Multivessel Disease

Functional Assessment of Coronary Stenoses: Hyperemic, Non-Hyperemic, and Angiographic Alternative Indices

IVUS Guided PCI: New Expansion Threshold

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos